Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing JAK2V617F, a driver mutation product for the treatment of myeloproliferative neoplasms...
41 insider purchases on record · latest filing 2026-04-23.
Insiders have also filed 67 sale transactions at PRLD.